Fred Alger Management, LLC Amgen Inc Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

A detailed history of Fred Alger Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 280,881 shares of AMGN stock, worth $74 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

280,881

Previous 325,752 13.77%

Holding current value

$74 Million

Previous $102 Million 11.08%

% of portfolio

0.46%

Previous 0.51%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $13.9 Million - $15.1 Million	-44,871 Reduced 13.77%	280,881 $90.5 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $48.1 Million - $58.5 Million	183,151 Added 128.44%	325,752 $102 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $77.1 Million - $93.1 Million	-286,906 Reduced 66.8%	142,601 $40.5 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $85.5 Million - $96.5 Million	334,436 Added 351.77%	429,507 $124 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $18.8 Million - $23.4 Million	86,134 Added 963.79%	95,071 $25.6 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $198,628 - $234,873	927 Added 11.57%	8,937 $1.98 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $32,739 - $39,904	145 Added 1.84%	8,010 $1.94 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $9,390 - $11,931	41 Added 0.52%	7,865 $2.07 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $34.1 Million - $38.4 Million	-151,871 Reduced 95.1%	7,824 $1.76 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $4.41 Million - $4.91 Million	-19,124 Reduced 10.69%	159,695 $38.9 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $38.2 Million - $42.2 Million	174,143 Added 3724.19%	178,819 $43.2 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $71,000 - $81,253	357 Added 8.27%	4,676 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $418,341 - $464,119	-1,791 Reduced 29.31%	4,319 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $13,415 - $15,975	-62 Reduced 1.0%	6,110 $1.41 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $12,462 - $15,292	63 Added 1.03%	6,172 $1.46 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $25,695 - $34,079	-141 Reduced 2.26%	6,109 $1.24 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $2,263 - $2,712	-13 Reduced 0.21%	6,250 $1.21 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $48,009 - $56,278	-288 Reduced 4.4%	6,263 $1.15 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $1.86 Million - $2.1 Million	-10,304 Reduced 61.13%	6,551 $1.25 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.8 Million - $2.1 Million	10,069 Added 148.38%	16,855 $3.28 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $1.47 Million - $1.66 Million	-7,928 Reduced 53.88%	6,786 $1.41 Million
Q2 2018 Jul 19, 2018	BUY	$166.05 - $186.51 $1.31 Million - $1.47 Million	7,895 Added 115.78%	14,714 $2.72 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $12,707 - $14,850	75 Added 1.11%	6,819 $1.16 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $120,347 - $134,464	-713 Reduced 9.56%	6,744 $1.17 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.25 Million - $1.42 Million	7,457	7,457 $1.39 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Amgen Inc Transaction History